|
146
|
534
|
1lwcA |
Crystal structure of m184v mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
17
|
99
|
1mesA |
Hiv-1 mutant (i84v) protease complexed with dmp323 |
|
16
|
99
|
1m0bA |
Hiv-1 protease in complex with an ethyleneamine inhibitor |
|
102
|
423
|
1lweB |
Crystal structure of m41l/t215y mutant hiv-1 reverse transcriptase (rtmn) in complex with nevirapine |
|
15
|
99
|
1merA |
Hiv-1 mutant (i84v) protease complexed with dmp450 |
|
141
|
539
|
1lw2A |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with 1051u91 |
|
116
|
422
|
1lw0B |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1metA |
Hiv-1 mutant (v82f) protease complexed with dmp323 |
|
109
|
423
|
1lwfB |
Crystal structure of a mutant hiv-1 reverse transcriptase (rtmq+m184v: m41l/d67n/k70r/m184v/t215y) in complex with nevirapine |
|
3
|
55
|
1mfsA |
Dynamical behavior of the hiv-1 nucleocapsid protein; nmr, 30 structures |
|
17
|
99
|
1kzkA |
Je-2147-hiv protease complex |
|
0
|
9
|
1kjhP |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
14
|
99
|
1kj4A |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kjhA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
1
|
8
|
1kj4P |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
0
|
9
|
1kjgP |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kj7A |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
16
|
99
|
1kjgA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kjfA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
17
|
99
|
1k2cA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
17
|
99
|
1k6cA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
133
|
539
|
1jlfA |
Crystal structure of y188c mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
18
|
99
|
1k1uA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
19
|
99
|
1k2bA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
17
|
99
|
1k6pA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
18
|
99
|
1k1tA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
19
|
99
|
1k6tA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
65
|
210
|
1k6yA |
Crystal structure of a two-domain fragment of hiv-1 integrase |
|
18
|
99
|
1k6vA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
111
|
435
|
1jlaB |
Crystal structure of y181c mutant hiv-1 reverse transcriptase in complex with tnk-651 |
|
16
|
99
|
1hxwA |
Hiv-1 protease dimer complexed with a-84538 |
|
14
|
99
|
1hteA |
X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of hiv-1 protease |
|
96
|
430
|
1hquB |
Human immunodeficiency virus type 1 |
|
54
|
154
|
1hyvA |
Hiv integrase core domain complexed with tetraphenyl arsonium |
|
17
|
99
|
1hwrA |
Molecular recognition of cyclic urea hiv protease inhibitors |
|
14
|
99
|
1hshA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
122
|
556
|
1hpzA |
Human immunodeficiency virus type 1 |
|
135
|
554
|
1hqeA |
Human immunodeficiency virus type 1 |
|
17
|
99
|
1hosA |
Inhibition of human immunodeficiency virus-1 protease by a c2-symmetric phosphinate synthesis and crystallographic analysis |
|
17
|
99
|
1idaA |
Crystal structures of hiv-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere |
|
16
|
99
|
1hvkA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
17
|
99
|
1hvlA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
13
|
99
|
1hsgA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
15
|
99
|
1hvrA |
Rational design of potent, bioavailable, nonpeptide cyclic ureas as hiv protease inhibitors |
|
14
|
99
|
1hsiA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
37
|
130
|
1hrhA |
Crystal structure of the ribonuclease h domain of hiv-1 reverse transcriptase |
|
137
|
558
|
1hnvA |
Structure of hiv-1 rt(slash)tibo r 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors |
|
16
|
99
|
1hvjA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
17
|
99
|
1hpxA |
Hiv-1 protease complexed with the inhibitor kni-272 |
|
13
|
99
|
1hpoA |
Hiv-1 protease triple mutant/u103265 complex |
